BTTX (Better Therapeutics) Accounts Payable: $2.31 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Better Therapeutics Accounts Payable?

Better Therapeutics BTTX Accounts Payable is $2.31 Mil as of Sep. 2023.

Better Therapeutics's Accounts Payable for the quarter that ended in Sep. 2023 was $2.31 Mil.

Better Therapeutics's quarterly Accounts Payable increased from Mar. 2023 ($2.51 Mil) to Jun. 2023 ($2.99 Mil) but then declined from Jun. 2023 ($2.99 Mil) to Sep. 2023 ($2.31 Mil).

Better Therapeutics's annual Accounts Payable increased from Dec. 2020 ($0.51 Mil) to Dec. 2021 ($1.52 Mil) and increased from Dec. 2021 ($1.52 Mil) to Dec. 2022 ($3.04 Mil).

Better Therapeutics Accounts Payable Related Terms

Better Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Accounts Payable Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Accounts Payable
0.34 0.51 1.52 3.04

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.26 3.04 2.51 2.99 2.31

Better Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.31 Mil mean?
Better Therapeutics (BTTX) has a Accounts Payable of $2.31 Mil as of Sep. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' Accounts Payable too high?
Better Therapeutics' current Accounts Payable is $2.31 Mil.
How does Better Therapeutics' Accounts Payable compare to CYCN and CELZ?
Better Therapeutics' Accounts Payable of $2.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current Accounts Payable is $2.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Accounts Payable of $2.31 Mil. The current Accounts Payable is $2.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Accounts Payable is $2.31 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.